-Gilead loses 3 executives in the last 6 months, but that's not why I sold!
-New research suggests that closed-loop insulin delivery-glucose monitoring keeps type 2 diabetics in range better than conventional therapy
this is not investment advice
-Gilead loses 3 executives in the last 6 months, but that's not why I sold!
-New research suggests that closed-loop insulin delivery-glucose monitoring keeps type 2 diabetics in range better than conventional therapy
this is not investment advice